In vitro enzymatic combinatorial selection and split-synthesis chemical combinatorial methods will be used to develop a """"""""ThioAptamer Chip"""""""" (TACh) for proteomics - a diagnostic tool to identify and quantify the differential expression of key proteins in response to pathogens of concern for bioterrorism threat (BT). This new proteomics technology will utilize our proprietary thioselection and phosphorothioate-modified oligonucleotide """"""""thioaptamers,"""""""" combined with the surface enhanced laser desorption/ionization (SELDI) mass spectroscopy technology of our collaborating partner, Ciphergen, to target both rodent and human proteomes. In particular we will study the inflammatory response of cytokines and key transcription factors (e.g., NF-kappaB) challenged with BT agents. The five NF-?B/Rel family proteins can combine to form 15 homo- and heterodimers, each performing a specific signaling function upon translocation across the cell nuclear membrane and binding to a gene's promoter region. In partnership with Ciphergen, we will also develop new, massively parallel, thioaptamer bead-based screening of the proteome with SELDI mass-spectrometric methods to identify uncharacterized proteins involved in the immune response to BT viruses. Our results from the TACh/SELDI approaches will be validated by 2D gel mass spectrometric proteomic methods. We will also apply bioinformatic analyses to correlate changes in protein expression with available genomic data on changes in gene expression as a result of inflammation after viral infection or shock. Elucidating these protein expression changes will allow early diagnosis and enhanced prognosis of viral disease, and subsequent development of effective pharmacological and immunological interventions. Specific initial viral targets include arenaviruses, Pichinde and Lassa (the latter on both the NIH and CDC class A lists).
| Kang, Shin-Ae; Hasan, Nafis; Mann, Aman P et al. (2015) Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis. Mol Ther 23:1044-1054 |
| Lu, Emily; Elizondo-Riojas, Miguel-Angel; Chang, Jeffrey T et al. (2014) Aptaligner: automated software for aligning pseudorandom DNA X-aptamers from next-generation sequencing data. Biochemistry 53:3523-5 |
| Gandham, Sai Hari A; Volk, David E; Lokesh, Ganesh L R et al. (2014) Thioaptamers targeting dengue virus type-2 envelope protein domain III. Biochem Biophys Res Commun 453:309-15 |
| He, Weiguo; Elizondo-Riojas, Miguel-Angel; Li, Xin et al. (2012) X-aptamers: a bead-based selection method for random incorporation of druglike moieties onto next-generation aptamers for enhanced binding. Biochemistry 51:8321-3 |
| Elizondo-Riojas, Miguel-Angel; Chamow, Steven M; Tuthill, Cynthia W et al. (2011) NMR structure of human thymosin alpha-1. Biochem Biophys Res Commun 416:356-61 |
| Somasunderam, Anoma; Thiviyanathan, Varatharasa; Tanaka, Takemi et al. (2010) Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44. Biochemistry 49:9106-12 |
| Volk, David E; May, Fiona J; Gandham, Sai H A et al. (2009) Structure of yellow fever virus envelope protein domain III. Virology 394:12-8 |
| Bowick, Gavin C; Fennewald, Susan M; Zhang, Lihong et al. (2009) Attenuated and lethal variants of Pichinde virus induce differential patterns of NF-kappaB activation suggesting a potential target for novel therapeutics. Viral Immunol 22:457-62 |
| Volk, David E; Anderson, Kurtis M; Gandham, Sai H A et al. (2008) NMR assignments of the sylvatic dengue 1 virus envelope protein domain III. Biomol NMR Assign 2:155-7 |
| Kang, Jonghoon; Lee, Myung Soog; Copland 3rd, John A et al. (2008) Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein. Bioorg Med Chem Lett 18:1835-9 |
Showing the most recent 10 out of 34 publications
